• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊利诺伊州庞贝病的新生儿筛查:684,290名婴儿的经验。

Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants.

作者信息

Burton Barbara K, Charrow Joel, Hoganson George E, Fleischer Julie, Grange Dorothy K, Braddock Stephen R, Hitchins Lauren, Hickey Rachel, Christensen Katherine M, Groepper Daniel, Shryock Heather, Smith Pamela, Shao Rong, Basheeruddin Khaja

机构信息

Department of Pediatrics, Feinberg School of Medicine of Northwestern University, Chicago, IL 60611, USA;

Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA;

出版信息

Int J Neonatal Screen. 2020 Jan 21;6(1):4. doi: 10.3390/ijns6010004. eCollection 2020 Mar.

DOI:10.3390/ijns6010004
PMID:33073003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7422983/
Abstract

Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing.

摘要

2015年,伊利诺伊州开始在全州范围内对庞贝病进行新生儿筛查。截至2019年9月30日,共有684,290名婴儿接受了筛查,其中395名婴儿(0.06%)筛查呈阳性。共确诊29例庞贝病(3例婴儿型,26例晚发型)。虽然其余许多婴儿在后续检测中发现α-葡萄糖苷酶活性正常(395例中有234例),但其他检测结果包括62名携带者、39名假缺陷婴儿,以及8名因后续检测结果不确定而无法明确诊断的婴儿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/7422983/18a113f45cd0/IJNS-06-00004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/7422983/18a113f45cd0/IJNS-06-00004-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/7422983/18a113f45cd0/IJNS-06-00004-g001.jpg

相似文献

1
Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants.伊利诺伊州庞贝病的新生儿筛查:684,290名婴儿的经验。
Int J Neonatal Screen. 2020 Jan 21;6(1):4. doi: 10.3390/ijns6010004. eCollection 2020 Mar.
2
A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations.一名通过新生儿筛查在症状出现前确诊的晚发型庞贝病婴儿:病例报告、家长经历及建议
Int J Neonatal Screen. 2020 Mar 14;6(1):22. doi: 10.3390/ijns6010022. eCollection 2020 Mar.
3
Newborn Screening for Pompe Disease: Pennsylvania Experience.庞贝病的新生儿筛查:宾夕法尼亚州的经验
Int J Neonatal Screen. 2020 Nov 13;6(4):89. doi: 10.3390/ijns6040089.
4
Newborn screening for Pompe disease in Italy: Long-term results and future challenges.意大利庞贝病新生儿筛查:长期结果与未来挑战
Mol Genet Metab Rep. 2022 Oct 22;33:100929. doi: 10.1016/j.ymgmr.2022.100929. eCollection 2022 Dec.
5
Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease.在庞贝病新生儿筛查中,质谱分析法而非荧光分析法可区分患病和假缺陷患者。
Clin Chem. 2017 Jul;63(7):1271-1277. doi: 10.1373/clinchem.2016.269027. Epub 2017 Apr 27.
6
The First Year Experience of Newborn Screening for Pompe Disease in California.加利福尼亚州庞贝氏病新生儿筛查的第一年经验
Int J Neonatal Screen. 2020 Feb 7;6(1):9. doi: 10.3390/ijns6010009. eCollection 2020 Mar.
7
A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.台湾一项针对庞贝氏症的大规模全国新生儿筛查计划:迈向有效诊断与治疗
Am J Med Genet A. 2014 Jan;164A(1):54-61. doi: 10.1002/ajmg.a.36197. Epub 2013 Nov 15.
8
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.伊利诺伊州溶酶体贮积症的新生儿筛查:最初15个月的经验
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
9
Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.通过新生儿筛查确定的婴儿型和晚发型庞贝病患者的基线尿葡萄糖四糖浓度。
JIMD Rep. 2015;19:67-73. doi: 10.1007/8904_2014_366. Epub 2015 Feb 15.
10
Current status of newborn screening for Pompe disease in Japan.日本庞贝病新生儿筛查的现状。
Orphanet J Rare Dis. 2021 Dec 18;16(1):516. doi: 10.1186/s13023-021-02146-z.

引用本文的文献

1
Latest Advancements in Treatment Options for Infantile-Onset Pompe Disease: A Comprehensive Narrative Review.婴儿型庞贝病治疗方案的最新进展:一篇全面的叙述性综述
Clin Med Insights Pediatr. 2025 Aug 11;19:11795565251337900. doi: 10.1177/11795565251337900. eCollection 2025.
2
Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders Emphasizes the Need for Multitier Testing and Collaborative Approaches to Management.溶酶体贮积症新生儿筛查挑战的探索性研究强调多层检测及协作管理方法的必要性。
JIMD Rep. 2025 Jun 16;66(4):e70027. doi: 10.1002/jmd2.70027. eCollection 2025 Jul.
3

本文引用的文献

1
GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe Registry.1079 例庞贝病患者的 GAA 变异体和表型:来自庞贝登记处的数据。
Hum Mutat. 2019 Nov;40(11):2146-2164. doi: 10.1002/humu.23878. Epub 2019 Aug 7.
2
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.在接受治疗性蛋白治疗的患者的 ERT 初治环境中使用短暂低剂量甲氨蝶呤的免疫耐受方法:婴儿期发病庞贝病的经验。
Genet Med. 2019 Apr;21(4):887-895. doi: 10.1038/s41436-018-0270-7. Epub 2018 Sep 14.
3
Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening.
An Assessment of Dietary Intake, Feeding Practices, Growth, and Swallowing Function in Young Children with Late-Onset Pompe Disease: A Framework for Developing Nutrition Guidelines.
晚发性庞贝病幼儿的膳食摄入量、喂养方式、生长发育及吞咽功能评估:制定营养指南的框架
Nutrients. 2025 Jun 1;17(11):1909. doi: 10.3390/nu17111909.
4
Global variations in diagnostic methods and epidemiological estimates in Pompe disease: findings from a scoping review.庞贝病诊断方法与流行病学估计的全球差异:一项范围综述的结果
Orphanet J Rare Dis. 2025 May 6;20(1):216. doi: 10.1186/s13023-025-03679-3.
5
Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of Therapies.生物标志物在疾病诊断、评估疾病严重程度和进展以及评价治疗效果中的作用。
J Inherit Metab Dis. 2025 May;48(3):e70034. doi: 10.1002/jimd.70034.
6
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe disease.通过肽偶联吗啉代寡核苷酸进行剪接校正作为晚发型庞贝病的一种新疗法。
Mol Ther Nucleic Acids. 2025 Mar 27;36(2):102524. doi: 10.1016/j.omtn.2025.102524. eCollection 2025 Jun 10.
7
Long-Term Health Outcomes of Individuals With Pseudodeficiency Alleles in IDUA May Inform Newborn Screening Practices for Mucopolysaccharidosis Type I.艾杜糖醛酸酶(IDUA)中假性缺陷等位基因个体的长期健康结局可能为I型黏多糖贮积症的新生儿筛查实践提供参考。
Am J Med Genet A. 2025 Apr;197(4):e63940. doi: 10.1002/ajmg.a.63940. Epub 2024 Nov 19.
8
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.
9
Global carrier frequency and predicted genetic prevalence of patients with pathogenic sequence variants in autosomal recessive genetic neuromuscular diseases.常染色体隐性遗传神经肌肉疾病中致病性序列变异患者的全球携带频率和预测遗传流行率。
Sci Rep. 2024 Feb 15;14(1):3806. doi: 10.1038/s41598-024-54413-1.
10
The Importance of Early Treatment of Inherited Neuromuscular Conditions.遗传性神经肌肉疾病的早期治疗的重要性。
J Neuromuscul Dis. 2024;11(2):253-274. doi: 10.3233/JND-230189.
4 年新生儿筛查中 4 种溶酶体贮积症的发病率。
JAMA Pediatr. 2018 Jul 1;172(7):696-697. doi: 10.1001/jamapediatrics.2018.0263.
4
Severe Cardiac Involvement Is Rare in Patients with Late-Onset Pompe Disease and the Common c.-32-13T>G Variant: Implications for Newborn Screening.迟发性庞贝病患者的严重心脏受累罕见,常见的 c.-32-13T>G 变异:对新生儿筛查的影响。
J Pediatr. 2018 Jul;198:308-312. doi: 10.1016/j.jpeds.2018.02.007. Epub 2018 Apr 4.
5
Sustained immune tolerance induction in enzyme replacement therapy-treated CRIM-negative patients with infantile Pompe disease.在接受酶替代疗法治疗的婴儿型庞贝病CRIM阴性患者中诱导持续的免疫耐受。
JCI Insight. 2017 Aug 17;2(16). doi: 10.1172/jci.insight.94328.
6
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.伊利诺伊州溶酶体贮积症的新生儿筛查:最初15个月的经验
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
7
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes.婴儿型庞贝病的极早期治疗有助于获得更好的预后。
J Pediatr. 2016 Feb;169:174-80.e1. doi: 10.1016/j.jpeds.2015.10.078. Epub 2015 Dec 10.
8
Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.通过新生儿筛查确定的婴儿型和晚发型庞贝病患者的基线尿葡萄糖四糖浓度。
JIMD Rep. 2015;19:67-73. doi: 10.1007/8904_2014_366. Epub 2015 Feb 15.
9
Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.溶酶体贮积症筛查实施情况:密苏里州全面人群试点测试头六个月的发现。
J Pediatr. 2015 Jan;166(1):172-7. doi: 10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18.
10
Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.评估庞贝病的疾病严重程度:尿四糖生物标志物和成像技术的作用。
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):50-8. doi: 10.1002/ajmg.c.31320. Epub 2012 Jan 17.